Latest filing published 21 May 2024 for Humacyte, Inc., €23k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Max N. Wallace: trading record in brief
Max N. Wallace is a declared insider of Humacyte, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 4 filings, for trades running from 26 August 2021 to 20 May 2024.
On the market, this insider has only ever bought: 2 purchases, €46k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant and 1 option exercise. In 2024 alone, the filings show 2 purchases and no sales.
Most recently, on 21 May 2024, the filings show an open-market purchase worth €23k in Humacyte, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Max N. Wallace
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,015 shares@ US$6.2176.3% of flowCommon StockSEC:0001818382-24-000067:0Canonical exit: 18 Aug 2024 (T+90)
- 6,564 shares@ US$1.1923.7% of flowCommon StockSEC:0001818382-23-000165:0
- 49,986 sharesCommon StockSEC:0001104659-21-110531:0
3 of 3 declarations